Earnings Feed
Sign Up
Home/Filings/4/0001127602-21-020199
4//SEC Filing

Brennan Troyen A 4

Accession 0001127602-21-020199

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:04 PM ET

Size

17.2 KB

Accession

0001127602-21-020199

Insider Transaction Report

Form 4
Period: 2021-06-15
CVS HEALTH CorpCVS
Brennan Troyen A
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-06-15$62.21/sh+65,681$4,086,015→ 210,378.059 total
  • Sale

    Common Stock

    2021-06-15$86.00/sh−67,552$5,809,472→ 142,826.059 total
  • Exercise/Conversion

    Stock Option

    2021-06-15−65,681→ 21,894 total
    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (65,681 underlying)
Holdings

  • Common Stock (restricted)

    4,805

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (75,134 underlying)
    75,134

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (112,637 underlying)
    112,637

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (53,772 underlying)
    53,772

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (47,937 underlying)
    47,937

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (161,605 underlying)
    161,605

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (99,344 underlying)
    99,344
Footnotes (9)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001351402

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:04 PM ET
Size
17.2 KB
View on SEC.gov